IFM Investors Pty Ltd Purchases 5,107 Shares of CME Group Inc. (NASDAQ:CME)


Share on StockTwits

IFM Investors Pty Ltd lifted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 17.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 34,564 shares of the financial services provider’s stock after buying an additional 5,107 shares during the period. IFM Investors Pty Ltd’s holdings in CME Group were worth $6,292,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. McGuire Investment Group LLC boosted its position in shares of CME Group by 0.3% during the 4th quarter. McGuire Investment Group LLC now owns 48,488 shares of the financial services provider’s stock worth $8,827,000 after acquiring an additional 147 shares in the last quarter. Pinnacle Bank raised its stake in CME Group by 24.7% during the fourth quarter. Pinnacle Bank now owns 404 shares of the financial services provider’s stock worth $74,000 after buying an additional 80 shares during the last quarter. First Citizens Bank & Trust Co. raised its stake in CME Group by 11.6% during the fourth quarter. First Citizens Bank & Trust Co. now owns 20,197 shares of the financial services provider’s stock worth $3,677,000 after buying an additional 2,100 shares during the last quarter. CX Institutional increased its stake in CME Group by 55.5% in the fourth quarter. CX Institutional now owns 465 shares of the financial services provider’s stock valued at $85,000 after purchasing an additional 166 shares in the last quarter. Finally, First Hawaiian Bank bought a new stake in CME Group in the fourth quarter valued at $253,000. Institutional investors and hedge funds own 83.88% of the company’s stock.

In other news, Director Martin J. Gepsman sold 800 shares of the company’s stock in a transaction on Tuesday, December 1st. The shares were sold at an average price of $178.60, for a total value of $142,880.00. Following the completion of the sale, the director now owns 29,817 shares of the company’s stock, valued at approximately $5,325,316.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Martin J. Gepsman sold 400 shares of the company’s stock in a transaction on Monday, December 14th. The shares were sold at an average price of $178.44, for a total transaction of $71,376.00. Following the completion of the sale, the director now directly owns 29,417 shares of the company’s stock, valued at approximately $5,249,169.48. The disclosure for this sale can be found here. Insiders sold a total of 17,100 shares of company stock valued at $2,960,709 in the last ninety days. 1.20% of the stock is owned by corporate insiders.

CME has been the subject of several research analyst reports. Barclays lifted their price target on shares of CME Group from $200.00 to $215.00 and gave the company an “overweight” rating in a research note on Tuesday. Rosenblatt Securities decreased their price target on shares of CME Group from $140.00 to $135.00 and set a “sell” rating for the company in a research note on Wednesday, January 6th. BidaskClub raised shares of CME Group from a “strong sell” rating to a “sell” rating in a research note on Sunday, November 29th. Atlantic Securities raised shares of CME Group from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $176.00 to $195.00 in a research note on Wednesday, September 23rd. Finally, JPMorgan Chase & Co. raised shares of CME Group from an “underweight” rating to a “neutral” rating and boosted their target price for the stock from $138.00 to $203.00 in a research report on Thursday, January 7th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $188.06.

Shares of NASDAQ:CME opened at $197.95 on Thursday. The company’s fifty day moving average price is $183.30 and its 200-day moving average price is $170.61. The firm has a market capitalization of $71.06 billion, a price-to-earnings ratio of 32.99, a PEG ratio of 15.03 and a beta of 0.46. CME Group Inc. has a one year low of $131.80 and a one year high of $225.36. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, October 28th. The financial services provider reported $1.38 EPS for the quarter, missing the Zacks’ consensus estimate of $1.41 by ($0.03). The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.09 billion. CME Group had a return on equity of 9.22% and a net margin of 43.68%. During the same period in the previous year, the company earned $1.90 EPS. As a group, equities research analysts expect that CME Group Inc. will post 6.73 EPS for the current year.

The business also recently declared a None dividend, which was paid on Wednesday, January 13th. Stockholders of record on Monday, December 28th were issued a $2.50 dividend. The ex-dividend date of this dividend was Thursday, December 24th. CME Group’s payout ratio is 50.00%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions.

Further Reading: What is Green Investing?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.